Google Alert - lose weight

	lose weight As-it-happens update ⋅ June 8, 2026
	NEWS
	expert reaction to two studies looking at AstraZeneca's GLP 1 pill, elecoglipron, for reducing ... Science Media Centre “In adults with obesity or overweight without diabetes, elecoglipron produced dose-dependent weight loss, with average weight reductions of up to 10.5 ... Flag as irrelevant
	Novo Nordisk, Eli Lilly roll out obesity pills, prepare for Medicare coverage - CNBC CNBC CEO Dave Ricks at ADA. Novo and Lilly are preparing for millions of seniors with Medicare to become eligible for GLP-1 drugs for weight loss for $50 a ... Flag as irrelevant
	AstraZeneca obesity pill helps patients lose 10.5% of body weight in trial | Reuters Reuters AstraZeneca said on Monday that patients lost 10.5% of their body weight after 26 weeks in a mid-stage trial of ​its experimental obesity pill, ... Flag as irrelevant
	AstraZeneca's Obesity Pill Helps Patients Lose Weight in Midstage Trials - Morningstar Morningstar The U.K. drugmaker said Monday that the medicine, elecoglipron, resulted in 11.8% weight loss after 36 weeks of treatment in a phase 2 study in ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Google Alert - lose weight

	lose weight As-it-happens update ⋅ June 8, 2026
	NEWS
	Want to lose weight? Influencer who shed 55 kg reveals the 7 foods she gave up The Economic Times Fitness influencer Dolly shared her weight loss journey, revealing that eliminating seven food categories helped her reduce calorie intake and ... Flag as irrelevant
	The hormone that could change weight loss medicine Duke University School of Medicine The science behind next-generation obesity drugs may come down to an unexpected player: glucagon, a hormone that boosts energy expenditure for ... Flag as irrelevant
	Man describes experience with experimental weight loss drug retatrutide: "I couldn't sleep" YouTube The weight loss drug retatrutide has been touted as "Ozempic on steroids." It's still in clinical trials and not approved by the FDA, ... Flag as irrelevant
	How YOU can lose a stone in just six weeks: I gained weight in midlife and had fat that ... - Daily Mail Daily Mail But Dorte Jensen is perhaps proof that not all weight loss methods lead, ultimately, to failure. The 54-year-old Pilates instructor lost nearly half a ... Flag as irrelevant
	Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug - MarketWatch MarketWatch Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts. Flag as irrelevant
	Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in ... PR Newswire PRNewswire/ -- Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced detailed results from three Phase 3 trials ... Flag as irrelevant
	Telehealth Booms As Demand For GLP-1s Surges - Neurology Advisor Neurology Advisor HealthDay News — Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor, ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback

Google Alert - lose weight

	lose weight As-it-happens update ⋅ June 8, 2026
	NEWS
	No, regaining weight after losing it won't permanently damage your metabolism – new research The Conversation ... fat, less muscle, greater hunger, lower energy, and an ever-diminishing ability to lose weight again. For those looking to lose weight, the so ... Flag as irrelevant
	Exercise vs diet: What you need to know about losing weight - YouTube YouTube A new study is changing what many of us believe about exercise when you are trying to lose weight. Welcome to the official YouTube channel of WJXT ... Flag as irrelevant
	Muscle growth drug 'could reduce loss of lean tissue' when using slimming jabs The Guardian Trial suggests monoclonal antibody can help retain lean body mass when losing weight with GLP-1 medicines. Flag as irrelevant
	Ozempic butt: Drug to stop muscle loss side effect of obesity jabs - BBC BBC A third of the weight loss from obesity jabs can come from muscle, say experts. Flag as irrelevant
	Optimal Body Weight Loss Program - YouTube YouTube International weight loss expert Dr. Cory Aplin explains a process to address "metabolic friction" that may make losing weight after 40 more ... Flag as irrelevant
	Why Personalization In Weight Loss Matters - TMJ4 TMJ4 When it comes to weight loss, there is no one-size-fits-all solution. Milwaukee Medical Weight Loss & Medispa explains how factors can influence a ... Flag as irrelevant
	Apitegromab for lean mass preservation during tirzepatide-induced weight loss - Nature Nature Loss of lean mass in proportion to total weight loss is observed with incretin mimetic therapies such as tirzepatide and has the potential to ... Flag as irrelevant
	The surprising hormone behind the next generation of weight-loss drugs Duke University School of Medicine First came GLP-1s for weight loss, now researchers like Jonathan Campbell, PhD, right, are studying what happens when the hormone glucagon joins the ... Flag as irrelevant
	Shrinking your waist size: six strategies for success - Edwards Air Force Base Edwards Air Force Base ... lose body fat,” states Wilkens. Examples of highly processed foods ... While losing weight requires burning more calories than you consume ... Flag as irrelevant
	A drug may help people on GLP-1 meds preserve muscle - Science News Science News GLP-1 drugs can spark drastic and rapid weight loss. But not all the weight lost is fat. Some 25 to 40 percent is lean body mass, which includes a ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback